The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis
Open accessAbstract
STUDY QUESTION: Can a panel of plasma protein biomarkers be identified to accurately and specifically diagnose endometriosis? SUMMARY ANSWER: A novel panel of 10 plasma protein biomarkers was identified and validated, demonstrating strong predictive accuracy for the diagnosis of endometriosis. WHAT IS KNOWN ALREADY: Endometriosis poses intricate medical challenges for affected individuals and their physicians, yet diagnosis currently takes an average of 7 years and normally requires invasive laparoscopy. Consequently, the need for a simple, accurate non-invasive diagnostic tool is paramount. STUDY DESIGN, SIZE, DURATION: This study compared 805 participants across two independent clinical populations, with the status of all endometriosis and symptomatic control samples confirmed by laparoscopy. A proteomics workflow was used to identify and validate plasma protein biomarkers for the diagnosis of endometriosis. PARTICIPANTS/MATERIALS, SETTING, METHODS: A proteomics discovery experiment identified candidate biomarkers before a targeted mass spectrometry assay was developed and used to compare plasma samples from 464 endometriosis cases, 153 general population controls, and 132 symptomatic controls. Three multivariate models were developed: Model 1 (logistic regression) for endometriosis cases versus general population controls, Model 2 (logistic regression) for rASRM stage II to IV (mild to severe) endometriosis cases versus symptomatic controls, and Model 3 (random forest) for stage IV (severe) endometriosis cases versus symptomatic controls. MAIN RESULTS AND THE ROLE OF CHANCE: A panel of 10 protein biomarkers were identified across the three models which added significant value to clinical factors. Model 3 (severe endometriosis vs symptomatic controls) performed the best with an area under the receiver operating characteristic curve (AUC) of 0.997 (95% CI 0.994–1.000). This model could also accurately distinguish symptomatic controls from early-stage endometriosis when applied to the remaining dataset (AUCs ≥0.85 for stage I to III endometriosis). Model 1 also demonstrated strong predictive performance with an AUC of 0.993 (95% CI 0.988–0.998), while Model 2 achieved an AUC of 0.729 (95% CI 0.676–0.783). LIMITATIONS, REASONS FOR CAUTION: The study participants were mostly of European ethnicity and the results may be biased from undiagnosed endometriosis in controls. Further analysis is required to enable the generalizability of the findings to other populations and settings. WIDER IMPLICATIONS OF THE FINDINGS: In combination, these plasma protein biomarkers and resulting diagnostic models represent a potential new tool for the non-invasive diagnosis of endometriosis. STUDY FUNDING/COMPETING INTEREST(S): Subject recruitment at The Royal Women’s Hospital, Melbourne, was supported in part by funding from the Australian National Health and Medical Research Council (NHMRC) project grants GNT1105321 and GNT1026033 and Australian Medical Research Future Fund grant no. MRF1199715 (P.A.W.R., S.H.-C., and M.H.). Proteomics International has filed patent WO 2021/184060 A1 that relates to endometriosis biomarkers described in this manuscript; S.B., R.L., and T.C. declare an interest in this patent. J.I., S.B., C.L., D.I., H.L., K.P., M.D., M.M., M.R., P.T., R.L., and T.C. are shareholders in Proteomics International. Otherwise, the authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging results from a proteomic screen of serum samples from a large cohort of 805 patients showed promise using a combination of 10 serum protein biomarkers with strong predictive accuracy for the diagnosis of endometriosis, particularly those with severe endometriosis (Stage IV).24”
From Steroid hormone profiling reveals altered adrenal androgen production in endometriosis (2026) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Classification and Regression by randomForest
Liaw, A. I., & Wiener, M. C. (2007) · Cited by 18,594
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749
Building Predictive Models in R Using the caret Package
Kuhn, M. (2008) · Journal of Statistical Software · doi:10.18637/jss.v028.i05 · Cited by 8,863
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
Zondervan, K. T., Becker, C. M., & Missmer, S. A. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1810764 · Cited by 2,249
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864
pwr: Basic Functions for Power Analysis
Champely, S. (2006) · CRAN: Contributed Packages · doi:10.32614/cran.package.pwr · Cited by 550
Imaging modalities for the non-invasive diagnosis of endometriosis
Nisenblat, V., Bossuyt, P. M., Farquhar, C., Johnson, N., & Hull, M. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009591.pub2 · Cited by 538
Research works printed but not linked: 2
- Ito, 2019, Biomarkers of Endometriosis
- Lipscombe, Endometriosis Biomarkers (Patent WO2021184060A1).
Cited by
Steroid hormone profiling reveals altered adrenal androgen production in endometriosis
Simitsidellis, I., Ainslie, R. J., Taylor, A. E., Gilligan, L. C., Shaheen, F., Blanke, S., Anderson, C., Hapangama, D., Arlt, W., Horne, A. W., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag109 · Cited by 1
“24 Similarly, an undisclosed panel of salivary miRNAs has been reported to detect endometriosis with high sensitivity but whether any of these markers vary across different populations, endometriosis subtypes or menstrual cycle stage is still unknown.”
Metadata
- Authors
- Schoeman, E. M., Bringans, S., Peters, K., Casey, T., Andronis, C., Chen, L., Duong, M., Girling, J. E., Healey, M., Boughton, B. A., Ismail, D., Ito, J., Laming, C., Lim, H., Mead, M., Raju, M., Tan, P., Lipscombe, R., Holdsworth-Carson, S., & Rogers, P. A. W.
- Affiliations
- Proteomics International , Nedlands, WA,
- Royal Women's Hospital (AU)
- La Trobe University (AU)
- Department of Obstetrics and Gynecology, University of Melbourne and Gynecology Research Centre, Royal Women’s Hospital , Melbourne, VIC,
- Corresponding author
- Peters, K
- ORCID
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-12-24
- Volume
- 40
- Issue
- 2
- Pages
- 270-279
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- PMC
- PMC11788222
- OpenAlex
- W4405753240
- Cited by
- 27
- References
- 35
- Citations by year
- 2026: 17 · 2025: 10
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Human Reproduction (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- Funders
- The Royal Women’s Hospital
- National Health and Medical Research Council (GNT1105321, GNT1026033)
- Medical Research Future (MRF1199715)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- endometriosis, plasma protein biomarkers, non-invasive diagnosis, biomarker panel, endometriosis staging, random forest, logistic regression, proteomics, diagnostic accuracy, symptom management, biomarker validation, biomarker discovery
- MeSH terms
- Adult, Blood Proteins, Endometriosis, Female, Humans, Middle Aged, Models, Statistical, Biomarkers, Case-Control Studies, Proteomics, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis. https://app.cochat.ai/papers/10.1093/humrep/deae278
- The paper
- Schoeman, E. M., Bringans, S., Peters, K., Casey, T., Andronis, C., Chen, L., Duong, M., Girling, J. E., Healey, M., Boughton, B. A., Ismail, D., Ito, J., Laming, C., Lim, H., Mead, M., Raju, M., Tan, P., Lipscombe, R., Holdsworth-Carson, S., & Rogers, P. A. W. (2025). Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis. Human Reproduction. https://doi.org/10.1093/humrep/deae278
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.